Conversely, cervical [25], colorectal [26], ovarian [27], and breast cancer studies reported that the high level of lipocalin-2 expression was associated with poor differentiated tumors, higher lymph node metastasis, and higher tumor stage. The gene discussed is LCN2; the disease is breast carcinoma.